Mastering the Management of IBD: Challenging Cases

Friday, October 20, 2023

 5:45 pm - 6:00 pm PT  Registration and Meal

6:00 pm - 7:30 pm PT  Presentation



The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly, as novel pharmacologic agents continue to advance the treatment of Crohn’s disease and ulcerative colitis. In this live symposium, 3 IBD experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification, treat-to-target approaches, and therapeutic monitoring. The symposium will be presented in a “Test and Teach” format that will pose challenging, case-based questions to the audience to explore the learner’s current knowledge and therapeutic approach, and then “teach” through them in-depth, evidence-based discussion. The program will conclude with an interactive audience Q&A session. 


Back Stage Pass Logo




Enhance Your Virtual Experience With Backstage Pass!

Join our 30-minute post-symposium breakout session connecting the program speakers and audience in the virtual environment. Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video Encouraged*




This activity is intended for gastroenterologists, primary care physicians, nurse practitioners, physician assistants, and other healthcare professionals involved in the care of patients with IBD.


The goal of this activity is for learners to be better able to manage patients and achieve sustained remission in patients with IBD by individualizing treatment based on disease assessment and risk stratification.


Upon completion of this activity, participants will: Have increased knowledge regarding the: [LIST] [ITEM]Risk/benefit profiles for new and emerging IBD therapies[/LIST] Have greater competence related to: [LIST] [ITEM]Using evidence-based criteria to assess risk for disease progression in patients with IBD [ITEM]Evaluating and modifying IBD treatment strategies based on treat-to-target principles [ITEM]Including patient-reported outcomes in evaluating treatment response[/LIST]


[JALOGO][MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fairmont Waterfront
Room: Waterfront Ballroom AB

900 Canada Pl 
Vancouver, , BC V6C 3L5